Litigation Details for PURDUE PHARMA L.P. v. ELITE LABORATORIES INC (D.N.J. 2023)
✉ Email this page to a colleague
PURDUE PHARMA L.P. v. ELITE LABORATORIES INC (D.N.J. 2023)
| Docket | ⤷ Start Trial | Date Filed | 2023-11-09 |
| Court | District Court, D. New Jersey | Date Terminated | |
| Cause | 35:271 Patent Infringement | Assigned To | Karen M. Williams |
| Jury Demand | None | Referred To | Ann Marie Donio |
| Patents | 10,407,434; 11,304,908; 11,304,909; 9,073,933; 9,492,389; 9,492,391; 9,492,392; 9,492,393; 9,522,919; 9,763,933; 9,770,416; 9,775,808 | ||
| Link to Docket | External link to docket | ||
Small Molecule Drugs cited in PURDUE PHARMA L.P. v. ELITE LABORATORIES INC
The small molecule drugs covered by the patents cited in this case are ⤷ Start Trial , ⤷ Start Trial , and ⤷ Start Trial .
Details for PURDUE PHARMA L.P. v. ELITE LABORATORIES INC (D.N.J. 2023)
| Date Filed | Document No. | Description | Snippet | Link To Document |
|---|---|---|---|---|
| 2023-11-09 | External link to document | |||
| 2023-11-09 | 1 | Complaint | ’909 patent”); 9,073,933 (“the ’933 patent”); 9,522,919 (“the ’919 patent”); 10,407,434 (“the ’434 patent… FOR RELIEF (PATENT INFRINGEMENT OF U.S. PATENT NO. 10,407,434) 145. Plaintiffs…United States Patent Nos. 9,763,933 (“the Mannion ’933 patent”); 9,770,416 (“the ’416 patent”); 9,492,389…9,492,389 (“the ’389 patent”); 9,492,391 (“the ’391 patent”); 9,492,392 (“the ’392 patent”); 9,492,393 (“the…the ’393 patent”); 9,775,808 (“the ’808 patent”); 11,304,908 (“the ’908 patent”); 11,304,909 (“the ’909 | External link to document |
| >Date Filed | >Document No. | >Description | >Snippet | >Link To Document |
